NICE OKs Remicade, Enbrel and Humira for psoriatic arthritis
This article was originally published in Scrip
Executive Summary
NICE, the health technology appraisal institute for England and Wales, says that physicians can now prescribe Abbott's Humira (adalimumab), Wyeth's Enbrel (etanercept) and Merck & Co's Remicade (infliximab) for some NHS patients with psoriatic arthritis. The institute issued final guidance along these lines this week.